Publication | Closed Access

The INVICTUS rheumatic heart disease research program: Rationale, design and baseline characteristics of a randomized trial of rivaroxaban compared to vitamin K antagonists in rheumatic valvular disease and atrial fibrillation

RheumatologyCardiovascular DiseaseRheumatic DiseasesPharmacologyCardiovascular PharmacologyPharmacotherapyRandomized TrialBaseline CharacteristicsAtrial FibrillationPublic HealthMedicineAnticoagulantCardiology